GSK
GSK admits: Execs ‘breached Chinese law’
July 22, 2013Medical Communications, Sales and Marketing China, GSK, bribes, scandal
A senior GlaxoSmithKline executive has admitted that some of the firm’s staff have broken the law in China as a …
GSK finance director barred from leaving China
July 18, 2013Medical Communications, Sales and Marketing GSK, bribes, corruption, hong
GlaxoSmithKline’s finance director and British citizen Steve Nechelput has been stopped from the leaving China as the bribery case into …
GSK exec admits bribery on live TV
July 16, 2013Medical Communications, Sales and Marketing China, GSK, bribery, cctv
A senior member of GSK China has appeared on state television admitting the firm’s guilt in the ongoing bribery allegations. …
China accuses GSK of large scale bribery
July 12, 2013Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat
Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …
GSK files cancer combination
July 10, 2013Sales and Marketing FDA, GSK, Tafinlar, mekinist
GlaxoSmithKline has put in supplemental applications for its Tafinlar/Mekinist combination – a pair of drugs which analysts predict may have …
GSK teams up with Oxford biotech on cancer
July 9, 2013Research and Development, Sales and Marketing GSK, Oxford, immunocore
GlaxoSmithKline has announced a partnership with a UK biotech firm to develop oncology medicines using new methods to fight the …
GSK China probe extends to Botox sales
July 8, 2013Sales and Marketing Botox, China, GSK, whistleblower
GlaxoSmithKline’s woes in China are continuing as the firm’s sales tactics with Botox are put under scrutiny. The London-based firm …
GSK under investigation in China
July 4, 2013Sales and Marketing China, GSK, NDRC, corruption
GlaxoSmithKline is being investigated by authorities in China in what appear to be two separate probes into the UK manufacturer’s …
Sanofi chief executive to lead EFPIA
June 26, 2013Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty
Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …
GSK mulling sales of thrombosis brands and facility to Aspen
June 24, 2013Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen
GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …
GSK receives thrombosis offer
June 19, 2013Sales and Marketing GSK, aspen, thrombosis
GlaxoSmithKline has received an offer from South African firm Aspen Global Incorporated (AGI) to buy its injectable thrombosis treatments and …
GSK fires head of China research over data fraud
June 11, 2013Research and Development China, GSK, Jingwu Zang, MS, autoimmune
GlaxoSmithKline has dismissed its vice president of research in China in connection with ‘misrepresentation’ of research data.Jingwu Zang had been senior …
GSK licences RA drug
June 5, 2013Research and Development, Sales and Marketing GSK, RA, morphosys
GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …
FDA approves GSK cancer drugs
May 30, 2013Sales and Marketing FDA, GSK
The FDA has approved two of GlaxoSmithKline’s cancer pills: BRAF-inhibitor Tafinlar and the first validated MEK-inhibitor, called Mekinist, both of …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
